For citations:
Zhukova O.V., Khokhlov A.L. Clinical and economic constituents of the application of dexamethasone and tocilizumab in the therapy for severe conditions in patients with COVID-19. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2021;14(1):16-27. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2021.060
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 